How Kangmei Pharmaceutical’s Regulatory Crackdown and Debt Crisis Are Shaking Its Future
Regulatory probe, hidden debt, and legal battles plunge KANGMEI Pharmaceutical into crisis—why investors face mounting risk and how governance failures spark a market collapse.
3 minutes to read